Session Details

[O17]Oral Session 17 Cancer Genetics 2

Sat. Oct 12, 2024 3:25 PM - 4:15 PM JST
Sat. Oct 12, 2024 6:25 AM - 7:15 AM UTC
Room 5(Highness Hall, 2F)
Chairs:Reiko Yoshida(Saitama Cancer Center Department of Molecular Diagnosis and Cancer Prevention), Yataro Daigo(Department of Medical Oncology and Cancer Center, Shiga University of Medical Science / Institute of Medical Science Hospital, The University of Tokyo)

[O17-1]Establishment of Medical Collaboration System for Hereditary Breast and Ovarian Cancer in the Central Area of Kanagawa

Rika Kawata1, Naomi Araki1,12, Sachiko Ohori1,12, Takafumi Sangai3,12, Kazuyoshi Kato4,12, Seigi Furukawa1,4,12, Hideyasu Tsumura1,5,12, Kosuke Okuwaki6,12, Mina Waraya1,7,12, Masao Araki1,8,12, Hiroshi Nishimiya8,12, Tsutomu Arai9,12, Hasegawa Tetsuya10,12, Yoshimasa Kosaka11,12, Fumio Takada1,2,12 (1.Division of Genetics, Kitasato University Hospital, Kanagawa, Japan, 2.Department of Medical Genetics and Genomics, Kitasato University Graduated School of Medical Sciences, Kanagawa, Japan, 3.Department of Breast and Thyroid Surgery, Kitasato University School of Medicine, Kanagawa, Japan, 4.Department of Obstetrics and Gynecology, Kitasato University School of Medicine, Kanagawa, Japan, 5.Department of Urology, Kitasato University of Medicine, Kanagawa, Japan, 6.Department of Gastroenterology, Kitasato University School of Medicine, Kanagawa, Japan, 7.Sagamino Hospital, Kanagawa, Japan, 8.Sagamihara Kyodo Hospital, Kanagawa, Japan, 9.Sagamihara National Hospital, Kanagawa, Japan, 10.Yamato Municipal Hospital, Kanagawa, Japan, 11.Japanese Red Cross Sagamihara Hospital, Kanagawa, Japan, 12.Kanagawa HBOC Kitasato Consortium, Kanagawa, Japan)

[O17-2]Issues in pancreatic cancer surveillance in hereditary breast and ovarian cancer syndrome

Dai Inoue, Wataru Yamagata, Megumi Takahara, Eri Soga, Minako Matsuda, Shuusuke Yasuura, Yuuji Miyoshi, Eri Yokota, Miho Isaka, Kumiko Yabuki, Izumi Honda (Department of Clinical Genomics)

[O17-3]Management of patients with presumed germline pathogenic variant from comprehensive genomic profiling tests

Hiroshi Miyamoto1, Ayuka Mineda2, Sawaka Yukishige3, Souichiro Sasa3, Kei Daizumoto4, Tomoya Fukawa4, Yasuyuki Okada1, Yasuhiro Mitsui1, Koichi Okamoto1, Yasushi Sato1, Hiroyuki Morino5, Tetsuji Takayama1 (1.Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 2.Department of Obstetrics and Gynecology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 3.Department of Thoracic, Endocrine Surgery and Oncology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 4.Department of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 5.Department of Medical Genetics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan)

[O17-4]Profiles of pathogenic variant carriers of Lynch syndrome found in a population-based research biobank participants

Kinuko Ohneda1, Masanobu Takahashi2, Yoichi Suzuki1,3, Yohei Hamanaka1,4, Junko Minato5, Muneaki Shimada5,6, Yumi Yamaguchi-Kabata1, Shu Tadaka1, Kengo Kinoshita1,6,7, Hiroshi Kawame1,8, Fuji Nagami1,6, Nobuo Fuse1,6, Yamamoto Masayuki1,6 (1.Division of Genomics and Disease prevention, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan, 2.Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan, 3.Department of Clinical Genetics, Ageo Central General Hospital, Ageo, Saitama, Japan, 4.Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan, 5.Department of Gynecology and Obstetrics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan, 6.Advanced Research Center for Innovations in Next-Generation Medicine, Tohoku University, Sendai, Miyagi, Japan, 7.Laboratory of Systems Bioinformatics, Graduate School of Information Sciences, Tohoku University, Sendai, Miyagi, Japan, 8.Department of Clinical Genetics, Jikei University Hospital, Tokyo, Japan)

[O17-5]Characterization of URST1 as a novel prognostic biomarker and therapeutic target for oral cancer

Atsushi Takano1,2,3, Yoshinori Yoshitake4, Masanori Shinohara4, Yataro Daigo1,2,3 (1.Center for Antibody and Vaccine Therapy, Institute of Medical Science Hospital, The University of Tokyo, 2.Department of Medical Oncology and Cancer Center, Shiga University of Medical Science, 3.Center for Advanced Medicine against Cancer, Shiga University of Medical Science,, 4.Department of Oral and Maxillofacial Surgery, Kumamoto University)